A statewide trauma comparison reported higher drug findings and a substantial rise in screening frequency. Changes in ascertainment complicate interpreting the trend as increased exposure alone.
The historical comparison
The study divided pediatric trauma records into 2009–2016 and 2017–2019. Drug-screen collection rose from 6.9% to 23.3%, while recorded benzodiazepine findings and opioid findings increased.
Injury patterns and ventilator duration also changed. These were concurrent trends, not a randomized exposure experiment.
Testing changes the denominator
More frequent or differently targeted screening can uncover exposures previously unrecorded. A rise in recorded findings therefore cannot be assigned entirely to a rise in community use.
The registry comparison also does not by itself determine whether a finding reflected prescribed, emergency-treatment, or nonmedical exposure in every case. A urine finding cannot establish incident-time impairment. The paper supports examining pediatric exposure and testing practices together, while an individual trauma opinion needs the sample time, treatment record, test method, and injury circumstances before attributing causation.
Source paper
Original analysis of the supplied journal article, identified as PMC9251080.
Leave a Reply